Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Net Cash Flow (2016 - 2026)

Ironwood Pharmaceuticals' Net Cash Flow history spans 16 years, with the latest figure at $74.7 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 22743.43% to $74.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $127.2 million, a 3670.75% increase, with the full-year FY2025 number at $127.2 million, up 3670.75% from a year prior.
  • Net Cash Flow hit $74.7 million in Q4 2025 for Ironwood Pharmaceuticals, up from $47.6 million in the prior quarter.
  • Over the last five years, Net Cash Flow for IRWD hit a ceiling of $84.1 million in Q1 2023 and a floor of -$565.5 million in Q2 2023.
  • Historically, Net Cash Flow has averaged -$7.4 million across 5 years, with a median of $24.6 million in 2024.
  • Biggest five-year swings in Net Cash Flow: plummeted 535.3% in 2023 and later skyrocketed 22743.43% in 2025.
  • Tracing IRWD's Net Cash Flow over 5 years: stood at $45.9 million in 2021, then surged by 78.87% to $82.0 million in 2022, then plummeted by 123.48% to -$19.3 million in 2023, then soared by 101.7% to $327000.0 in 2024, then skyrocketed by 22743.43% to $74.7 million in 2025.
  • Business Quant data shows Net Cash Flow for IRWD at $74.7 million in Q4 2025, $47.6 million in Q3 2025, and -$15.0 million in Q2 2025.